A framework for managing knowledge in strategic alliances in the biotechnology sector

Systems Research and Behavioral Science

Volumn 25, Issue 6, 2008, Pages 783-796

  Standing, Susan ^a   Standing, Craig ^a   Lin, Chad ^b  

^a EDITH COWAN UNIVERSITY   (Australia)

^b CURTIN UNIVERSITY   (Australia)

Author keywords

Biotechnology; Creative holism; Knowledge management; Strategic alliances; Systems approaches

Indexed keywords

ALLIANCE FORMATION; BIOTECHNOLOGY FIRMS; BIOTECHNOLOGY SECTORS; CREATIVE HOLISM; CRITICAL SYSTEMS; SMALL AND MEDIUM-SIZED ENTERPRISE; STRATEGIC ALLIANCE; SYSTEMS APPROACH;

BIOTECHNOLOGY; KNOWLEDGE MANAGEMENT;

INDUSTRY;

EID: 60349091269     PISSN: 10927026     EISSN: 10991743     Source Type: Journal    
DOI: 10.1002/sres.861     Document Type: Article

References (55)

1. Australian Government. 2007. Invest Australia. Emerging capabilities in Agribiotech. http://www.investaustralia.gov.au/index.cfm?id=557835C0-508 508B-A0EB-68B78411FE62F32D
2. Baeyens K, Vanacker T. 2006. Venture capitalists' selection process: the case of biotechnology proposals. International Journal of Technology Management 34(1-2): 28-46.
3. BarNir A, Smith KA. 2002. Interfirm alliances in the small business: the role of social networks. Journal of Small Business Management 40(3): 219-232.
4. Baum JAC, Silverman BS. 2004. Picking winners or building them? Alliance, intellectual, and human capital as selection criteria in venture financing and performance of biotechnology startups. Journal of Business Venturing 19: 411-436.
5. Bock G, Zmud R, Kim Y, Lee J. 2005. Behavioral intention formation in knowledge sharing: Examining the roles of extrinsic motivators, social-psychological forces, and organizational climate. MIS Quarterly 29(1): 87-112.
6. Cha M, Hutt PB. 2004. Pharma Biotech alliances: A case study. http://leda.law.harvard.edu/leda/data/625/Cha-redacted.html
7. Coleman J. 1988. Social capital in the creation of human capital. American Journal of Sociology 94: 95-120.
8. Das TK, He IY. 2006. Entrepreneurial firms in search of established partners: review and recommendations. International Journal of Entrepreneurial Behaviour and Research 12(3): 114-143.
9. Das TK, Teng B. 1998. Resource and risk management in the strategic alliance making process. Journal of Management 24(1): 21.-42.
10. Das TK, Teng B. 1999. Managing risks in strategic alliances. Academy of Management Executive 13(4): 50-62.
11. Das TK, Teng B. 2002. The dynamics of alliance conditions in the alliance development process. Journal of Management Studies 39(5): 725-746.
12. Davenport TH, Prusak L. 1997. Working Knowledge: How Organisations Manage What They Know. Harvard Business School Press: Cambridge, MA.
13. De Clercq D, Sapienza HJ. 2006. Effects of relational capital and commitment on venture capitalists' perception of portfolio company performance. Journal of Business Venturing 21(3): 326-347.
14. Delerue-Vidot H. 2006. Opportunism and unilateral commitment: the moderating effect of relational capital. Management Decision 44(6): 737-751.
15. Dyer JH. 1997. Effective interfirm collaboration: How firms minimize transaction costs and maximize transaction value. Strategic Management Journal 18(7): 535-556.
16. Ernst and Young. 2003. Swiss Biotech Report.
17. Ernst and Young. 2005. Swiss Biotech Report.
18. Fulton M, Giannakas K. 2001. Agricultural biotechnology and industry structure. AgBioForum 4(2): 137-151.
19. Graff GD, Rausser GC, Small AA. 2003. Agricultural biotechnology's complementary intellectual assets. The Review of Economics and Statistics 85(2): 349-363.
20. Hamel G. 1991. Competition for competence and InterPartner Learning within International Strategic Alliances. Strategic Management Journal 12: 83-103.
21. Inkpen AC, Dinur A. 1998. Knowledge management processes and international joint ventures. Organization Science 9(4): 454-468.
22. Jackson MC. 2003. Systems Thinking: Creative Holism for Managers. Wiley: Chichester.
23. Jackson MC. 2006. Creative holism.: a critical systems approach to complex problem solving. Systems Research and Behavioural Science 23(5): 647-659.
24. Kale P, Dyer J, Singh H. 2001. Value creation and success in strategic alliances: alliancing skills and the role of alliance structure and systems. European Management Journal 19(5): 463-471.
25. Ko D-G, Kirsch LJ, King WR. 2005. Antecedents of knowledge transfer from consultants to client in enterprise system implementations. MIS Quarterly 29(1): 59-86.
26. Lavoie BF, Sheldon IM. 2000. The comparative advantage of real options: an explanation for the US specialization in biotechnology. AgBioForum 3(1): 47-52.
27. Lin H-M. 2006. Interorganisational collaboration, social embeddedness, and value creation: a theoretical analysis. International Journal of Management 23(3-1): 548-558.
28. Lin C, Standing C, Liu Y-C. 2006. A framework to evaluate the effectiveness of virtual teams, Edith Cowan University Internal Research report.
29. Ma T, Liu S, Nakamori Y. 2006. Roadmapping as a way of knowledge management for supporting scientific research in academia. Systems Research and Behavioral Science 23(6): 743-755.
30. Majchrzak A, Rice RE, Malhotra A, King N, Ba S. 2000. Technology adaptation: the case of a computer-supported inter-organizational virtual team. MIS Quarterly 24(4): 569-600.
31. Malhotra A, Majchrzak A, Carman R, Lott V. 2001. Radical innovation without collocation: A case study at Boeing-Rocketdyne. MIS Quarterly 25(2): 229-249.
32. Malhotra A, Gosain S, EL Sawy OA. 2005. Absorptive capacity configurations in supply chains: Gearing for partner-enabled market knowledge creation. MLS Quarterly 29(1): 145-187.
33. Mandelbaum J. 2003. Biotech News. Allens Arthur Robinson. Accessed November 2006. http://www. aar.com.au/pu.bs/bt/28oct/print.pdf
34. Mardis, Abel, Associates. 2004. The management premium - the link between operational excellence and shareholder value in biotech firms. www.bioportfolio. com/
35. Maurer I, Ebers M. 2006. Dynamics of social capital and their performance implications: lessons from biotechnology start-ups. Administrative Science Quarterly 51(2): 262-292.
36. Miles G, Preece SB, Baetz MC. 1999. Dangers of dependence: the impact of strategic alliance use by small technology-based firms. Journal of Small Business Management 37(2): 20-29.
37. Nicholson S, Danzon PM, McCullough J. 2005. Biotech-pharmaceutical alliances as a signal of asset and firm quality. The Journal of Business 78(4): 1433-1464.
38. Nonaka I. 1994. A dynamic theory of organizational knowledge creation. Organizational Science. Linthicum 5(1): 14-37.
39. OECD. International Futures Programme. 2006. The bioeconomy to 2030: designing a policy agenda.
40. Pitt L, Merwq R, Berthon P, Salehi-Sabgaru E, Caruana A. 2006. Global alliance networks: a comparison of biotech SMEs in Sweden and Australia. Industrial Marketing Management 35(5): 600-610.
41. Prionics AG. 2006. http://www.pri.onics.com
42. Putnam RD. 1995. Bowling alone: America's declining social capital. Journal of Democracy 6(1): 65-78.
43. Ring PS. 2000. The three T's of alliance creation: task, team and time. European Management Journal 18(2): 152-163.
44. Rothaermel FT, Deeds DL. 2006. Alliance type, alliance experience and alliance management capability in high-technology ventures. Journal of Business Venturing 21(4): 429-460.
45. Sambamurthy V, Subramani M. 2005. Special issue on information technologies and knowledge management. MIS Quarterly 29(1): 1-7.
46. Sarkar MB, Cavysguk ST, Aulakh PS. 2001. The influence of complementarity, compatibility, and relationship capital on alliance performance. Journal of the Academy of Marketing Science 29(4): 358-373.
47. Shan W. 1990. An empirical analysis of organizational strategies by entrepreneurial high-technology firms. Strategic Management Journal 11:129-139.
48. Simon F, Kotler P. 2003. Building Global Biobrands: Taking Biotechnology to Market. Free Press, Simon & Schuster Inc.: New York.
49. Stone W, Hughes J. 2002. Social capital. Empirical meaning and measurement validity, http://www.aifs.gov.au/institute/pubs/RP27.pdf
50. Swiss American Business Council. 2004. Report on Biotechnology, Biomedicine and Bioinformatics 3 (2), p. 3. www.sabcnow.com/B3/ report/b3mara.pr04.pdf
51. Tan J. 2006. Growth of industry clusters and innovation: lessons from Beijing Zhongguancun science park. Journal of Business Venturing 21(6): 827-850.
52. Tanriverdi H. 2005. Information technology relatedness, knowledge management capability, and performance of multibusiness firms. MLS Quarterly 29(2): 311-335.
53. Vitale M. 2004. Commercialising Australian biotechnology. Australian Business Foundation, http://www.abfoundation.com.au/ext/Frame.nsf/pages/Research
54. Wang Y, Li H, Warfield. J, Xu L. 2006. Knowledge management in the ERP era. Systems Research and Behavioral Science 23(2): 125-128.
55. Zahra SA, George G. 2002. The net enabled business innovation cycle and the evolution of dynamic capabilities. Information Systems Research 13(2): 147-150.